Literature DB >> 3537213

Hepatic metastatic thymoma and myasthenia gravis twenty-two years after the apparent cure of an invasive thymoma. A case report and review of the literature.

M A Denayer, K R Rao, D Wirz, D McNally.   

Abstract

We report the case of a 62-year-old woman who presented in myasthenic crisis 22 years after radiation- and chemotherapy of an invasive thymoma which occurred during pregnancy. There was no evidence of recurrence of the thymoma at its original site, but an isolated hepatic metastasis was discovered. Biopsy of the mass revealed a spindle cell thymoma, whereas the original histology was that of a mixed round and spindle cell thymoma with moderate lymphocytic infiltration. The patient expired in spite of treatment with steroids, pyridostigmine bromide and plasma exchange on the one hand and cyclophosphamide with adriamycin on the other. To our knowledge, 22 years is the longest reported interval for the appearance of metastatic thymoma and myasthenia gravis after the diagnosis and apparent cure of a primary thymoma. This is also the only reported case of thymoma occurring during pregnancy but not associated with a rapidly fatal outcome.

Entities:  

Mesh:

Year:  1986        PMID: 3537213     DOI: 10.1016/0022-510x(86)90139-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  A novel second line chemotherapy treatment of recurrent thymoma.

Authors:  N Jan; G M Villani; J Trambert; C Fehmian; B Sood; P H Wiernik
Journal:  Med Oncol       Date:  1997 Sep-Dec       Impact factor: 3.064

2.  Polypoid endobronchial extension from invasive thymoma.

Authors:  K Honma; M Mishina; Y Watanabe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

3.  Myasthenia gravis appearing after thymectomy: a case report and review of the literature.

Authors:  Sa-Yoon Kang; Jung Seok Lee; Jay Chol Choi; Ji-Hoon Kang
Journal:  J Clin Neurol       Date:  2007-09-20       Impact factor: 3.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.